^
APOBEC mutagenesis
|
Urothelial Cancer
|
APOBEC mutagenesis
|
Urothelial Cancer
|
atezolizumab Sensitive: B - Late Trials
|
atezolizumab Sensitive: B - Late Trials
|
APOBEC mutagenesis
|
Urothelial Cancer
|
APOBEC mutagenesis
|
Urothelial Cancer
|
pembrolizumab Sensitive: C3 – Early Trials
|
pembrolizumab Sensitive: C3 – Early Trials
|
APOBEC mutagenesis
|
Urothelial Cancer
|
APOBEC mutagenesis
|
Urothelial Cancer
|
cisplatin Resistant: C3 – Early Trials
|
cisplatin Resistant: C3 – Early Trials
|
APOBEC mutagenesis
|
Urothelial Cancer
|
APOBEC mutagenesis
|
Urothelial Cancer
|
carboplatin Resistant: C3 – Early Trials
|
carboplatin Resistant: C3 – Early Trials
|
